The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a positive start to the week and in afternoon trade is up 0.4% to 5,726 points
Four shares which have had an even better start to the week are listed below. Here’s why they have started the week with strong gains:
The Avz Minerals Ltd (ASX: AVZ) share price has continued its strong run, rising a further 28% to 7.8 cents. As I mentioned earlier, investors have been fighting to get hold of Avz Minerals shares due to the significant potential of its Manono lithium project in the Democratic Republic of Congo. I believe it is certainly worth keeping a very close eye on.
The Fortescue Metals Group Limited (ASX: FMG) share price is up 4% to $5.66 thanks to the iron ore price jumping to a four-month high. According to the Financial Times, Chinese futures have risen as much as 7% on Monday after Chinese data revealed that construction sector activity has climbed to the highest level in over three and a half years.
The Kogan.com Ltd (ASX: KGN) share price has climbed 4% to $2.50. Although there was no news out of the company today, investors appear to be reacting positively to an announcement made at the end of last week which revealed that Kogan will soon start offering insurance products. Whilst I still wouldn’t be a buyer of its shares, I do like the way Kogan has continued to diversify its offering this year.
The Zelda Therapeutics Ltd (ASX: ZLD) share price is up 3% to 7 cents after the medicinal cannabis company advised of an expansion to its breast cancer research collaboration. According to the release, following positive early data which showed that its formulations had anti-cancer effects across different breast cancer cell lines, Zelda and Complutense University have extended the research now to investigate the effect of cannabinoids on cancer stem cell-like cells.
Missed out on gains? Grab these growth shares before they soar would be my advice.
For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..
But knowing which blue chips to buy, and when, can be fraught with danger.
The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."
Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.
The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.
Click here to claim your free report.
Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.